Skip to main content
. 2018 May 9;11(10):1600–1605. doi: 10.1002/cssc.201800617

Table 2.

Heatmap depicting the relative suitability of internal standards for various DFRC analytes.[a]

Analytes Difference in value compared to the deuterated analog [%]
tetracosane BPO DEDF H‐d 8 G‐d 8 S‐d 8 G‐pBA‐d 8 S‐pBA‐d 8 G‐DD pCA‐d 10 S‐DD pCA‐d 10 G‐DDFA‐d 10 S‐DDFA‐d 10
H‐OH/Ac 30 47 43 0 2 2 17 40 22 26 24 56
G‐OH/Ac 35 41 145 4 0 4 91 146 95 124 141 158
S‐OH/Ac 31 45 124 4 2 0 63 102 73 88 98 114
G‐pBA 3517 4580 54 29 14 19 0 43 15 17 3 62
S‐pBA 53 60 64 50 37 41 30 0 40 18 32 13
G‐DHpCA 308 308 9 44 50 47 27 34 0 17 6 46
S‐DHpCA 11 25 7 25 35 32 9 14 14 0 9 24
G‐DHFA 2123 2378 39 26 4 2 4 47 12 20 0 66
S‐DHFA 2133 2351 4 12 71 67 17 11 36 24 30 0

[a] =deuterated analogue, =<10 %, =10–25 %, =25–50 %, =>50 % difference.